For press inquiries click here to contact us.
The Huffington Post
An Implant Could Revolutionize The Way We Protect Ourselves From HIV
Ophthalmology Times
Novel ocular hypotensive drug meets endpoints
FierceBiotech
Pfizer wins quick reward from buyout of Anacor with approval of eczema drug expected to be blockbuster
FierceBiotech
Intellia gears up for human testing of CRISPR with new HQ, set to double staffers
The Boston Globe
Intarcia seeks approval of drug-device combo to treat Type 2 diabtes
Fortune
A New Innovation for Type 2 Diabetes
Bloomberg
Nestle Pays $145 Million for Stake in Biotech Firm Aimmune
Reuters
AstraZeneca licenses respiratory drug to Insmed
FierceBiotech
FierceBiotech’s Fierce 15 for 2016: Arcus Biosciences
Please see important disclaimers in the Terms section.
